198 related articles for article (PubMed ID: 11220371)
21. Secretory meningioma: a case report with immunohistochemical and ultrastructural study.
Adachi J; Kazumoto K; Uki J; Takeda F; Kurozumi M; Nakazato Y
Noshuyo Byori; 1993; 10(2):93-8. PubMed ID: 8220795
[TBL] [Abstract][Full Text] [Related]
22. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
23. Secretory meningioma with severe perifocal edema--case report.
Tsuzuki N; Nakau H; Sugaya M; Hashizume K; Matsukuma S; Wada R; Kuwabara N
Neurol Med Chir (Tokyo); 1997 Aug; 37(8):620-3. PubMed ID: 9301199
[TBL] [Abstract][Full Text] [Related]
24. Primary ear and temporal bone meningiomas: a clinicopathologic study of 36 cases with a review of the literature.
Thompson LD; Bouffard JP; Sandberg GD; Mena H
Mod Pathol; 2003 Mar; 16(3):236-45. PubMed ID: 12640104
[TBL] [Abstract][Full Text] [Related]
25. Skull base secretory meningioma. Value of histological and immunohistochemical findings for peritumoral brain edema formation.
Zielinski G; Grala B; Koziarski A; Kozlowski W
Neuro Endocrinol Lett; 2013; 34(2):111-7. PubMed ID: 23645307
[TBL] [Abstract][Full Text] [Related]
26. MIB-1 staining index and peritumoral brain edema of meningiomas.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
[TBL] [Abstract][Full Text] [Related]
27. Status of Ki-67, estrogen and progesterone receptors in various subtypes of intracranial meningiomas.
Fakhrjou A; Meshkini A; Shadrvan S
Pak J Biol Sci; 2012 Jun; 15(11):530-5. PubMed ID: 24191627
[TBL] [Abstract][Full Text] [Related]
28. [A case of multiple meningiomas: two lesions have different clinicopathological features, respectively].
Oshita J; Sogabe T; Maeda H; Sato H; Sugiyama K; Kurisu K
No Shinkei Geka; 2007 Sep; 35(9):929-34. PubMed ID: 17867314
[TBL] [Abstract][Full Text] [Related]
29. Secretory meningiomas.
Colakoğlu N; Demirtaş E; Oktar N; Yüntem N; Islekel S; Ozdamar N
J Neurooncol; 2003 May; 62(3):233-41. PubMed ID: 12777074
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral brain edema in intracranial meningiomas: effects of radiological and histological factors.
Tamiya T; Ono Y; Matsumoto K; Ohmoto T
Neurosurgery; 2001 Nov; 49(5):1046-51; discussion 1051-2. PubMed ID: 11846896
[TBL] [Abstract][Full Text] [Related]
31. Angiomatous meningioma: a clinicopathologic study of 38 cases.
Hasselblatt M; Nolte KW; Paulus W
Am J Surg Pathol; 2004 Mar; 28(3):390-3. PubMed ID: 15104303
[TBL] [Abstract][Full Text] [Related]
32. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
33. Correlation of clinical and biological parameters with peritumoral edema in meningioma.
Paek SH; Kim CY; Kim YY; Park IA; Kim MS; Kim DG; Jung HW
J Neurooncol; 2002 Dec; 60(3):235-45. PubMed ID: 12510775
[TBL] [Abstract][Full Text] [Related]
34. Multiple meningiomas consisting of fibrous meningioma and anaplastic meningioma.
Tomita T; Kurimoto M; Yamatani K; Nagai S; Kuwayama N; Hirashima Y; Endo S
J Clin Neurosci; 2003 Sep; 10(5):622-4. PubMed ID: 12948473
[TBL] [Abstract][Full Text] [Related]
35. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
36. p53 Protein expression in meningiomas - a clinicopathologic study of 55 patients.
Aguiar PH; Agner C; Simm R; Freitas AB; Tsanaclis AM; Plese P
Neurosurg Rev; 2002 Aug; 25(4):252-7. PubMed ID: 12172734
[TBL] [Abstract][Full Text] [Related]
37. Progesterone and estrogen receptors in meningiomas: prognostic considerations.
Hsu DW; Efird JT; Hedley-Whyte ET
J Neurosurg; 1997 Jan; 86(1):113-20. PubMed ID: 8988089
[TBL] [Abstract][Full Text] [Related]
38. Is progesteron receptor status really a prognostic factor for intracranial meningiomas?
Iplikcioglu AC; Hatiboglu MA; Ozek E; Ozcan D
Clin Neurol Neurosurg; 2014 Sep; 124():119-22. PubMed ID: 25036873
[TBL] [Abstract][Full Text] [Related]
39. Aquaporin-4 expression is increased in edematous meningiomas.
Ng WH; Hy JW; Tan WL; Liew D; Lim T; Ang BT; Ng I
J Clin Neurosci; 2009 Mar; 16(3):441-3. PubMed ID: 19153045
[TBL] [Abstract][Full Text] [Related]
40. Recurrence of benign meningiomas: predictive value of proliferative index, BCL2, p53, hormonal receptors and HER2 expression.
Abdelzaher E; El-Gendi SM; Yehya A; Gowil AG
Br J Neurosurg; 2011 Dec; 25(6):707-13. PubMed ID: 20979437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
